{"id":7395,"date":"2016-05-09T05:35:07","date_gmt":"2016-05-09T05:35:07","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/"},"modified":"2016-05-09T05:35:07","modified_gmt":"2016-05-09T05:35:07","slug":"nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/","title":{"rendered":"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO"},"content":{"rendered":"<h2>Pr\u00e9sentation de r\u00e9sultats sur les mol\u00e9cules d\u00e9velopp\u00e9es par Nicox NCX 667, NCX 1653 et NCX 4240, et de r\u00e9sultats sur le latanoprost\u00e8ne bunod par Bausch + Lomb, partenaire de Nicox<br \/>\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.<\/h2>\n<p>Sophia Antipolis, France<\/p>\n<p><strong>Nicox S.A<\/strong>. (Euronext Paris : FR0013018124, COX), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la pr\u00e9sentation de sept posters lors du dernier congr\u00e8s annuel de l\u2019ARVO (<em>Association for Research in Vision and Ophthalmology)<\/em>. Ces posters pr\u00e9sentent des donn\u00e9es scientifiques de produits candidats de son portefeuille, d\u00e9velopp\u00e9s en interne ou au travers de partenariats. L\u2019ARVO est l\u2019un des congr\u00e8s scientifiques de r\u00e9f\u00e9rence en ophtalmologie et s\u2019est tenu du 1er au 5 mai 2016 \u00e0 Seattle, \u00c9tats-Unis.<\/p>\n<p><strong>Le Dr. Michael Bergamini, Directeur Scientifique et Vice-pr\u00e9sident Ex\u00e9cutif de Nicox<\/strong>, commente : <em>\u00ab Au-del\u00e0 du latanoprost\u00e8ne bunod et de l\u2019AC-170, pour lesquels des demandes d\u2019autorisation de mise sur le march\u00e9 sont en cours d\u2019\u00e9valuation par la FDA aux \u00c9tats-Unis, Nicox poss\u00e8de un portefeuille de mol\u00e9cules prometteuses et propri\u00e9taires en ophtalmologie, ciblant des indications oculaires importantes, telles que la bl\u00e9pharite, le glaucome et certaines pathologies de la conjonctive. Lors de ce congr\u00e8s 2016 de l\u2019ARVO, Nicox a ainsi pr\u00e9sent\u00e9 trois posters sur ses produits candidats d\u00e9velopp\u00e9s en interne NCX 667, NCX 1653 et NCX 4240, en plus des communications de Bausch &amp; Lomb sur le latanoprost\u00e8ne bunod. Ces r\u00e9sultats pr\u00e9cliniques pr\u00e9sent\u00e9s fournissent les premi\u00e8res donn\u00e9es d\u2019efficacit\u00e9 et\/ou de s\u00e9curit\u00e9 et illustrent notre engagement \u00e0 continuer de d\u00e9velopper de nouveaux m\u00e9dicaments contre les pathologies oculaires utilisant notre plateforme technologique de compos\u00e9s donneurs d\u2019oxyde nitrique. \u00bb<\/em><\/p>\n<p>Les posters pr\u00e9sent\u00e9s lors de l\u2019ARVO 2016 sont indiqu\u00e9s ci-dessous et les abstracts ont \u00e9t\u00e9 publi\u00e9s sur le site du congr\u00e8s : <a href=\"http:\/\/www.arvo.org\/AM\/Program\">http:\/\/www.arvo.org\/AM\/Program<\/a><\/p>\n<p><strong><em>Posters sur le latanoprost\u00e8ne bunod<\/em><\/strong><\/p>\n<p><strong>Titre<\/strong> : <em>\u00ab Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Jason Vittitow, Bausch + Lomb<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3030 \u2013 A0379<br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n<p><strong>Titre<\/strong> :<em> \u00ab Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : James Peace, United Medical Research Institute<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3035 \u2013 A0384<br \/><strong>Lieu<\/strong> :<em> Exhibit\/Poster Hall<\/em><\/p>\n<p><strong>Titre<\/strong> : <em>\u00ab Integrated Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Paul Kaufman, University of Wisconsin School of Medicine and Public Health<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3036 \u2013 A0385<br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n<p><strong>Titre<\/strong> :<em> \u00ab Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Kazuhide Kawase, Gifu University Hospital<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3037 \u2013 A0386<br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n<p><em><strong>Posters sur les candidats m\u00e9dicaments de Nicox d\u00e9velopp\u00e9s en interne<\/strong><\/em><\/p>\n<p><strong>Titre<\/strong> : <em>\u00ab IOP-lowering effects of NCX 667 in combination with travoprost in ocular normotensive and transient hypertensive rabbits \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Elena Bastia, Nicox Research Institute<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3031 \u2013 A0380 <br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n<p><strong>Titre<\/strong> : <em>\u00ab Intraocular pressure-lowering and ocular exposure of NCX 1653, a novel nitric oxide-donating travoprost in models of ocular hypertension and glaucoma \u00bb<\/em><br \/><strong>Date<\/strong> : mardi 3 mai 2016 de 8h30 \u00e0 10h15, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Francesco Impagnatiello, Nicox Research Institute<br \/><strong>Session<\/strong> : \u00c9tudes cliniques sur le glaucome \/ Pharmacologie<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 3034 \u2013 A0383<br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n<p><strong>Titre<\/strong> : <em>\u00ab Anti-viral efficiency of NCX4240 (iota-carrageenan) eye drops against Adenoviruses (AdV) causing epidemic keratoconjunctivitis (EKC) \u00bb<\/em><br \/><strong>Date<\/strong> : mercredi 4 mai 2016 de 15h45 \u00e0 17h30, heure locale<br \/><strong>Pr\u00e9sentateur<\/strong> : Brigitte Duquesroix, Nicox<br \/><strong>Session<\/strong> : Inflammation<br \/><strong>N\u00b0 de l\u2019abstract et du poster<\/strong> : 5406 \u2013 B0146<br \/><strong>Lieu<\/strong> : <em>Exhibit\/Poster Hall<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pr\u00e9sentation de r\u00e9sultats sur les mol\u00e9cules d\u00e9velopp\u00e9es par Nicox NCX 667, NCX 1653 et NCX 4240, et de r\u00e9sultats sur le latanoprost\u00e8ne bunod par Bausch + Lomb, partenaire de Nicox\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la pr\u00e9sentation de sept posters lors du dernier [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7395","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox\" \/>\n<meta property=\"og:description\" content=\"Pr\u00e9sentation de r\u00e9sultats sur les mol\u00e9cules d\u00e9velopp\u00e9es par Nicox NCX 667, NCX 1653 et NCX 4240, et de r\u00e9sultats sur le latanoprost\u00e8ne bunod par Bausch + Lomb, partenaire de Nicox\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la pr\u00e9sentation de sept posters lors du dernier [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-09T05:35:07+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO\",\"datePublished\":\"2016-05-09T05:35:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/\"},\"wordCount\":739,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/\",\"name\":\"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2016-05-09T05:35:07+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox","og_description":"Pr\u00e9sentation de r\u00e9sultats sur les mol\u00e9cules d\u00e9velopp\u00e9es par Nicox NCX 667, NCX 1653 et NCX 4240, et de r\u00e9sultats sur le latanoprost\u00e8ne bunod par Bausch + Lomb, partenaire de Nicox\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la pr\u00e9sentation de sept posters lors du dernier [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/","og_site_name":"Nicox","article_published_time":"2016-05-09T05:35:07+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/"},"author":{"name":"","@id":""},"headline":"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO","datePublished":"2016-05-09T05:35:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/"},"wordCount":739,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/","url":"https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/","name":"Nicox annonce la pr\u00e9sentation de donn\u00e9es scientifiques au congr\u00e8s 2016 de l\u2019ARVO - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2016-05-09T05:35:07+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-annonce-la-presentation-de-donnees-scientifiques-au-congres-2016-de-larvo-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7395"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}